These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9202876)

  • 21. Letter: Catatonia.
    Freyhan FA
    Biol Psychiatry; 1976 Feb; 11(1):115-6. PubMed ID: 769849
    [No Abstract]   [Full Text] [Related]  

  • 22. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Catatonia in childhood and adolescence: obstacles to diagnosis and treatment].
    Spysschaert Y; Dhossche D; Sienaert P
    Tijdschr Psychiatr; 2016; 58(5):371-9. PubMed ID: 27213636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case series: catatonic syndrome in young people.
    Cohen D; Flament M; Dubos PF; Basquin M
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):1040-6. PubMed ID: 10434497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
    Northoff G; Wenke J; Pflug B
    Psychol Med; 1996 May; 26(3):547-53. PubMed ID: 8733213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders.
    Ungvari GS; Caroff SN; Gerevich J
    Schizophr Bull; 2010 Mar; 36(2):231-8. PubMed ID: 19776208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H
    J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECT in the treatment of the catatonic syndrome.
    Rohland BM; Carroll BT; Jacoby RG
    J Affect Disord; 1993 Dec; 29(4):255-61. PubMed ID: 8126312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catatonic syndrome following recovery from neuroleptic malignant syndrome.
    Dent J
    J Intellect Disabil Res; 1995 Oct; 39 ( Pt 5)():457-9. PubMed ID: 8555725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Features of the immune profile of schizophrenic patients with catatonic syndrome].
    Zakharova NV; Zozulya SA; Sarmanova ZV; Bravve LV; Otman IN; Klyushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6. Vyp. 2):46-53. PubMed ID: 32729690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Catatonia].
    Pot AL; Lejoyeux M
    Encephale; 2015 Jun; 41(3):274-9. PubMed ID: 25858694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The different conceptions of catatonia: historical overview and critical discussion.
    Pfuhlmann B; Stöber G
    Eur Arch Psychiatry Clin Neurosci; 2001; 251 Suppl 1():I4-7. PubMed ID: 11776270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rediscovering catatonia: the biography of a treatable syndrome.
    Fink M
    Acta Psychiatr Scand Suppl; 2013; (441):1-47. PubMed ID: 23215963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
    Häßler F; Reis O; Weirich S; Höppner J; Pohl B; Buchmann J
    Z Kinder Jugendpsychiatr Psychother; 2013 Jan; 41(1):69-74. PubMed ID: 23258439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders.
    Peter-Ross EM
    Med Hypotheses; 2018 Apr; 113():54-64. PubMed ID: 29523295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.